OSCR
Oscar Health Inc
$
14.200
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
15.9139
Open
15.750
VWAP
14.80
Vol
42.28M
Mkt Cap
3.62B
Low
14.110
Amount
625.54M
EV/EBITDA(TTM)
10.55
Total Shares
237.22M
EV
2.11B
EV/OCF(TTM)
1.72
P/S(TTM)
0.43
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
2.61B
+9.16%
-0.642
+3.52%
2.78B
+14.91%
-0.184
-16.45%
2.89B
+30.31%
0.355
+77.66%
Estimates Revision
The market is revising Upward the revenue expectations for Oscar Health, Inc. (OSCR) for FY2025, with the revenue forecasts being adjusted by 1.42% over the past three months. During the same period, the stock price has changed by 18.04%.
Revenue Estimates for FY2025
Revise Upward
+1.42%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-40.23%
In Past 3 Month
Stock Price
Go Up
+18.04%
In Past 3 Month
6 Analyst Rating
7.75% Upside
Wall Street analysts forecast OSCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 15.30 USD with a low forecast of 12.00 USD and a high forecast of 18.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
3 Sell
Moderate Sell
7.75% Upside
Current: 14.200
Low
12.00
Averages
15.30
High
18.00
7.75% Upside
Current: 14.200
Low
12.00
Averages
15.30
High
18.00
Barclays
Underweight
downgrade
$17 -> $11
2025-07-23
New
Reason
Barclays
Price Target
$17 -> $11
2025-07-23
New
downgrade
Underweight
Reason
Barclays lowered the firm's price target on Oscar Health to $11 from $17 and keeps an Underweight rating on the shares. The firm reduced estimates through 2027 following the earnings report.
UBS
Neutral -> Sell
downgrade
$15 -> $11
2025-07-15
Reason
UBS
Price Target
$15 -> $11
2025-07-15
downgrade
Neutral -> Sell
Reason
UBS downgraded Oscar Health to Sell from Neutral with a price target of $11, down from $15. The firm believes recent developments in the public health insurance exchanges create uncertainty that is not fully priced into the shares. UBS expects Oscar's exchange enrollment to fall at least 30% in 2026 when enhanced subsidies expire. The company will be unable to offset the membership loss with pricing, the analyst tells investors in a research note.
Wells Fargo
Equal Weight -> Underweight
downgrade
$16 -> $10
2025-07-11
Reason
Wells Fargo
Price Target
$16 -> $10
2025-07-11
downgrade
Equal Weight -> Underweight
Reason
Wells Fargo downgraded Oscar Health to Underweight from Equal Weight with a price target of $10, down from $16.
Wells Fargo
Equal Weight -> Underweight
downgrade
$16 -> $10
2025-07-11
Reason
Wells Fargo
Price Target
$16 -> $10
2025-07-11
downgrade
Equal Weight -> Underweight
Reason
Wells Fargo downgraded Oscar Health to Underweight from Equal Weight with a price target of $10, down from $16. The firm says evidence of rising exchange acuity continues to build for Oscar. Exchange commentary from almost all public plans in Q1 was concerning, the analyst tells investors in a research note. Wells believes 2025 pricing is not adequate to cover cost trends and increasing market acuity. Oscar Health's visibility could remain low for some time, the firm contends.
Barclays
Underweight
initiated
$17
2025-07-02
Reason
Barclays
Price Target
$17
2025-07-02
initiated
Underweight
Reason
Barclays initiated coverage of Oscar Health with an Underweight rating and $17 price target. After years of investing in growth, Oscar and new CEO Mark Bertolini laid out "a compelling path" to $2.25-plus in EPS in 2027 at the company's 2024 investor day, but several new policy risks have emerged since then beyond the expiration of enhanced subsidies, including integrity rules, CSR funding, and pharmacy tariffs, all of which put margin and growth targets at risk, the analyst tells investors.
Raymond James
Outperform -> Market Perform
downgrade
2025-06-24
Reason
Raymond James
Price Target
2025-06-24
downgrade
Outperform -> Market Perform
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Oscar Health Inc (OSCR.N) is 301.14, compared to its 5-year average forward P/E of 32.07. For a more detailed relative valuation and DCF analysis to assess Oscar Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
32.07
Current PE
301.14
Overvalued PE
101.28
Undervalued PE
-37.13
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.99
Current EV/EBITDA
-102.59
Overvalued EV/EBITDA
12.69
Undervalued EV/EBITDA
-10.71
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.51
Current PS
0.33
Overvalued PS
1.04
Undervalued PS
-0.02
Financials
Annual
Quarterly
FY2025Q1
YoY :
+42.20%
3.05B
Total Revenue
FY2025Q1
YoY :
+60.12%
297.12M
Operating Profit
FY2025Q1
YoY :
+55.23%
275.51M
Net Income after Tax
FY2025Q1
YoY :
+50.00%
0.90
EPS - Diluted
FY2025Q1
YoY :
+38.37%
869.52M
Free Cash Flow
FY2025Q1
YoY :
-1110.26%
11.82
FCF Margin - %
FY2025Q1
YoY :
+9.18%
9.04
Net Margin - %
FY2025Q1
9.55
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
2.7M
USD
8
0-12
Months
7.6M
USD
14
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
12
46.1M
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
3.6M
Volume
2
6-9
Months
5.5M
Volume
3
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
1.3M
Volume
Months
6-9
5
6.5M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
2.7M
USD
8
0-12
Months
7.6M
USD
14
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
12
46.1M
USD
Months
0-12
0
0.0
USD
Months
OSCR News & Events
Events Timeline
2025-07-23 (ET)
2025-07-23
12:57:26
Moderately bullish activity in Oscar Health with shares up 1.8%
2025-07-22 (ET)
2025-07-22
08:26:26
Oscar Health raises FY25 revenue view to $12.0B-$12.2B from $11.2B-$11.3B
2025-07-22
06:05:32
Oscar Health raises FY25 revenue view to $12.0B-$12.2B from $11.2B-$11.3B
Sign Up For More Events
Sign Up For More Events
News
9.5
07-22NASDAQ.COMPinnedOscar Health Announces Prelim. Q2 Results, Revises FY24 Revenue Outlook
4.5
07-22NASDAQ.COMPre-Market Most Active for Jul 22, 2025 : OPEN, TSLL, REPL, SQQQ, OSCR, NVDA, QS, RXRX, BBAI, JOBY, NIO, CVX
7.0
07-22NewsfilterOscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance
Sign Up For More News
People Also Watch
COMP
Compass Inc
7.130
USD
-1.66%
CARG
CarGurus Inc
33.630
USD
-1.12%
ASGN
ASGN Inc
55.650
USD
+11.26%
NXE
Nexgen Energy Ltd
7.430
USD
+4.80%
GHC
Graham Holdings Co
904.310
USD
-0.86%
M
Macy's Inc
12.700
USD
-0.63%
UCB
United Community Banks Inc
31.370
USD
-1.75%
FLG
Flagstar Financial Inc
12.050
USD
-3.14%
ENS
EnerSys
93.020
USD
-1.46%
PBH
Prestige Consumer Healthcare Inc
76.280
USD
-0.59%
FAQ
What is Oscar Health Inc (OSCR) stock price today?
The current price of OSCR is 14.2 USD — it has decreased -10.52 % in the last trading day.
What is Oscar Health Inc (OSCR)'s business?
What is the price predicton of OSCR Stock?
What is Oscar Health Inc (OSCR)'s revenue for the last quarter?
What is Oscar Health Inc (OSCR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Oscar Health Inc (OSCR)'s fundamentals?
How many employees does Oscar Health Inc (OSCR). have?